Home  /  Resource Library  /  Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an outpatient alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation

Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an outpatient alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation

Results of a study examining allogeneic stem cell transplant for treatment of cutaneous t-cell lymphomas.